TY - JOUR T1 - Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic JF - medRxiv DO - 10.1101/2020.05.29.20065714 SP - 2020.05.29.20065714 AU - Reza Yaesoubi AU - Joshua Havumaki AU - Melanie H. Chitwood AU - Nicolas A. Menzies AU - Gregg Gonsalves AU - Joshua Salomon AU - A David Paltiel AU - Ted Cohen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/01/2020.05.29.20065714.abstract N2 - Policymakers need decision tools to determine when to use physical distancing interventions to maximize the control of COVID-19 while minimizing the economic and social costs of these interventions. We develop a pragmatic decision tool to characterize adaptive policies that combine real-time surveillance data with clear decision rules to guide when to trigger, continue, or stop physical distancing interventions during the current pandemic. In model-based experiments, we find that adaptive policies characterized by our proposed approach prevent more deaths and require a shorter overall duration of physical distancing than alternative physical distancing policies. Our proposed approach can readily be extended to more complex models and interventions.One-sentence summaries Adaptive physical distancing policies save more lives with fewer weeks of intervention than policies which prespecify the length and timing of interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRY was supported by K01AI119603, and TC by R01AI112438 and R01AI146555, all from the National Institute of Allergy and Infectious Diseases. GG was supported by DP2DA49282 and ADP by R37DA015612 both from the National Institute on Drug Abuse.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data needed to replicate this study is included in the main text and the supplement. ER -